Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $7.4 million.

  • CG Oncology's Interest & Investment Income fell 596.81% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year increase of 2393.56%. This contributed to the annual value of $26.6 million for FY2024, which is 28563.15% up from last year.
  • According to the latest figures from Q3 2025, CG Oncology's Interest & Investment Income is $7.4 million, which was down 596.81% from $7.3 million recorded in Q2 2025.
  • Over the past 5 years, CG Oncology's Interest & Investment Income peaked at $7.9 million during Q3 2024, and registered a low of $771000.0 during Q2 2023.
  • For the 3-year period, CG Oncology's Interest & Investment Income averaged around $5.1 million, with its median value being $6.2 million (2024).
  • In the last 5 years, CG Oncology's Interest & Investment Income surged by 80051.88% in 2024 and then crashed by 596.81% in 2025.
  • Over the past 3 years, CG Oncology's Interest & Investment Income (Quarter) stood at $2.8 million in 2023, then surged by 122.72% to $6.2 million in 2024, then grew by 18.83% to $7.4 million in 2025.
  • Its last three reported values are $7.4 million in Q3 2025, $7.3 million for Q2 2025, and $7.7 million during Q1 2025.